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Altered physiology of gastrointestinal vagal afferents 
following neurotrauma
Emily N. Blanke2, Gregory M. Holmes2, Emily M. Besecker1, *
Abstract  
The adaptability of the central nervous system has been revealed in several model systems. 
Of particular interest to central nervous system-injured individuals is the ability for 
neural components to be modified for regain of function. In both types of neurotrauma, 
traumatic brain injury and spinal cord injury, the primary parasympathetic control to the 
gastrointestinal tract, the vagus nerve, remains anatomically intact. However, individuals 
with traumatic brain injury or spinal cord injury are highly susceptible to gastrointestinal 
dysfunctions. Such gastrointestinal dysfunctions attribute to higher morbidity and 
mortality following traumatic brain injury and spinal cord injury. While the vagal efferent 
output remains capable of eliciting motor responses following injury, evidence suggests 
impairment of the vagal afferents. Since sensory input drives motor output, this review 
will discuss the normal and altered anatomy and physiology of the gastrointestinal vagal 
afferents to better understand the contributions of vagal afferent plasticity following 
neurotrauma.
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Introduction 
Central nervous system (CNS) trauma, or neurotrauma, is a 
result of sudden insult or mechanical force to the head or 
spine (Chang and Badjatia, 2014; Wang et al., 2018; Yates et al., 
2019). The types of neurotrauma vary but include concussion, 
skull fractures, traumatic brain injury (TBI), spinal column 
fractures, and spinal cord injuries (SCI; Icahn, 2020). The World 
Health Organization (WHO) has recognized neurotrauma as a 
“critical public health problem” which leads to significant losses 
to the injured individual, the individual’s family, and the entire 
community as a result of lifelong disabilities or death (WHO, 
2020).  One comorbidity that is often overlooked following 
neurotrauma is dysregulation of the gastrointestinal (GI) organs 
associated with nutrient homeostasis. The function of the GI 
tract in health and disease is well-studied in the neurally-intact 
organism. Due to increased survivability after neurotrauma, 
it is imperative to understand the long-term consequences 
of neural injury and plasticity towards repair and regain of 
function of this vital organ system.
In the USA, there are approximately 1.7–2.0 million incidents 
of TBI annually (Huang, 2013; Wang et al., 2018), and 
there are about 5.3 million Americans currently living with 
permanent TBI-related comorbidities (Wang et al., 2018). 
These comorbidities include derangements in physical, 
emotional, and behavioral functions, neurocognitive 
disabilities (Langlois et al., 2006; McCrory et al., 2009; 
Daneshvar et al., 2011) and a vegetative state (McKee and 
Daneshvar, 2015). While there are both intracranial and 
extracranial complications post-TBI, the extracranial deficits 
are systemic and may involve any organ system. The most 
commonly affected organ systems include the vagally-
innervated respiratory, cardiovascular, and GI systems. GI 
dysfunctions following TBI (Pilitsis and Rengachary, 2001; Hang 
et al., 2003; Zygun et al., 2005; Kemp et al., 2008; Masel and 
DeWitt, 2010; Olsen et al., 2013; Katzenberger et al., 2015; 
Vance et al., 2015) affect greater than 50% (Qi et al., 2011) of 
TBI individuals and include impaired swallowing (Mackay et 
al., 1999; Morgan and Mackay, 1999), decreased pharyngeal 
sensation, prolonged transit, (Morgan and Mackay, 1999), 
GI bleeding (Kamada et al., 1977; Brown et al., 1989; Lu et 
al., 1997), gastric reflux (Saxe et al., 1994; Kao et al., 1998), 
delayed gastric emptying (Qi et al., 2011), decreased tone in 
the lower esophageal sphincter (Kamada et al., 1977; Brown 
et al., 1989; Philip, 1992; Saxe et al., 1994; Pedoto et al., 1995; 
Lu et al., 1997; Kao et al., 1998; Pilitsis and Rengachary, 2001), 
gastroparesis (Brown et al., 1989; Jackson and Davidoff, 1989; 
Pilitsis and Rengachary, 2001), decreased intestinal peristalsis 
(Philip, 1992; Pedoto et al., 1995), mucosal damage with 
increased gut permeability (Bansal et al., 2009; Katzenberger 
et al., 2015), and altered GI motility (Jackson and Davidoff, 
1989). Of the post-TBI GI complications, the most common 
comorbidity is gastritis with a reported incidence of 74–100% 
(Kamada et al., 1977; Brown et al., 1989). Lastly, 68% of TBI 
individuals suffer from chronic malnourishment (Horneman 
et al., 2005) which further exacerbates system-wide deficits 
from lack of nutrients. GI dysfunctions contribute to post-
TBI morbidity and mortality (Qi et al., 2011); yet, the exact 
mechanisms for GI dysfunctions following TBI remain unclear.
The devastating losses in motor, GI, bladder, and sexual 
function are continually rated as the top regain of function 
priorities for SCI individuals (Anderson, 2004; Simpson et 
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al., 2012; van Middendorp et al., 2016). Bladder and GI 
dysfunctions have been described as the “most debilitating” 
of these burdens because they not only impact the health of 
SCI individuals, but greatly limit their relationships and social 
interactions, further diminishing their quality of life (Simpson 
et al., 2012; Braaf et al., 2017). Specifically, reports indicate 
that high thoracic or cervical spinal trauma most often 
lead to delayed gastric emptying, early satiety, dysphagia, 
constipation, incontinence, nausea, bloating, and abdominal 
pain (Wolf and Meiners, 2003; Park and Camilleri, 2006; Fynne 
et al., 2012).  
Gastric functions and other upper GI functions are dominated 
by and dependent on extrinsic parasympathetic nervous 
system circuits for regulation (Browning and Travagli, 
2014; Travagli and Anselmi, 2016). The vagus nerve (VN) 
contains the visceral afferent and efferent fibers essential for 
parasympathetic nervous system-mediated reflexes. In both 
TBI and SCI, the VN remains anatomically intact following 
injury; however, evidence suggests that the parasympathetic 
nervous system and the enteric nervous system (ENS) 
within the gut no longer cooperatively coordinate GI 
functions suggesting a disruption in the vago-vagal reflexes. 
The normal anatomy and physiology of the VN has been 
extensively discussed by others (Lal et al., 2001; Browning 
and Mendelowitz, 2003; Undem et al., 2004; Blackshaw et 
al., 2007; Wang and Powley, 2007; Browning and Travagli, 
2011; Potenzieri et al., 2012; Holmes et al., 2013; Bonaz et 
al., 2016; Grabauskas and Owyang, 2017; Breit et al., 2018; 
Driessen, 2019; Fülling et al., 2019). For our purposes, the 
following brief summary of VN anatomy and physiology is 
provided to give a frame of reference for our discussion 
of vagal neuroplasticity following CNS trauma. This review 
highlights the role of the VN in GI sensory signaling and the 
neuroplasticity that occurs following TBI and SCI. 
The PubMed database was used between November 2019 
and January 2020, using the search terms: traumatic brain 
injury/TBI, spinal cord injury/SCI, stroke, nodose ganglia, vagal 
afferents, vagus nerve, microbiome, and various combinations 
of these search terms.
Normal Anatomy and Physiology of the Vagus 
Nerve 
Gastrointestinal vago-vagal reflex
The autonomic regulation of the GI tract in the context of 
SCI has recently been reviewed (Holmes and Blanke, 2019). 
Briefly, the VN is a central link in the brain-gut axis and 
contributes to the neural modulation of digestive (i.e., vago-
vagal) reflexes. The vagal afferents transmit glutamatergic 
signals to the nucleus tractus solitarius (NTS) in response 
to GI mechanical and chemical stimuli (Figure 1). Within 
the caudal medulla, NTS interneurons may inhibit or excite 
cholinergic vagal efferents of the dorsal motor nucleus of 
the vagus (DMV). These DMV efferent neurons complete the 
vago-vagal circuit (Browning and Travagli, 2010) by synapsing 
onto parasympathetic postganglionic cholinergic or non-
adrenergic non-cholinergic neurons in the submucosal and 
myenteric plexuses of the ENS. The functional response 
of the postganglionic enteric neurons may be excitatory 
causing an increase in GI tone, motility, and secretion or 
inhibitory preventing GI digestive functions (Travagli et al., 
2006; Browning and Travagli, 2011). Proper GI functioning 
is dependent upon vagal reflexes, and any disruption in the 
circuit leads to GI pathologies in the neurally intact including 
but not limited to gastroparesis, dyspepsia, esophageal reflux, 
colitis, anorexia and bulimia nervosa (Yamano et al., 1997; 
Hornby and Abrahams, 2000; Andrews and Sanger, 2002; 
Thumshirn, 2002; Saito et al., 2006; Ghia et al., 2007; Faris et 
al., 2008). 
Our research focuses on how CNS trauma modifies the GI 
vago-vagal reflex and leads to GI dysfunction. Previously, we 
have shown that gastric vagal efferents are intact following 
experimental SCI, and DMV neurons projecting to the stomach 
respond similarly to uninjured controls (Swartz and Holmes, 
2014). Vagal afferents demonstrate a significant amount of 
plasticity during both normal physiology and pathophysiology 
such as high fat diet, diabetes, inflammation, and direct vagal 
injury (Browning, 2003; Browning and Mendelowitz, 2003; 
Li and Owyang, 2003; Raybould, 2010; Dockray and Burdyga, 
2011; Kentish and Page, 2014; de Lartigue, 2016; Travagli 
and Anselmi, 2016; Browning et al., 2017; Grabauskas and 
Owyang, 2017; Cawthon and de La Serre, 2018; de Lartigue 
and Xu, 2018). Therefore, we propose that vagal afferent 
alterations may be, in part, responsible for GI dysfunction 
following neurotrauma. 
Gastrointestinal vagal afferent physiology
The GI vagal afferent cell bodies are contained within 
the nodose ganglia (NG) and have both peripheral and 
central projections (Figure 1). The vagal afferent terminal 
nerve endings are diffusely spread throughout layers of 
the walls of the proximal GI tract (reaching from mouth to 
transverse colon in humans (Rea, 2014) and distal colon 
in rats (Altschuler et al., 1993; Herrity et al., 2014). They 
consist of mechanoreceptor morphological specializations, 
known as intraganglionic laminar endings, for detecting 
tension and stretch in the muscle wall and intramuscular 
arrays which transduce stretch of the organ wall (Powley 
and Phillips, 2002). Additionally, chemical stimuli such as gut 
peptides like cholecystokinin (CCK) and ghrelin are detected 
by chemoreceptors (Powley and Phillips, 2002) on vagal 
afferent peripheral endings within GI mucosa or on the 
vagal afferent somas within the NG. CCK and ghrelin elicit 
opposite responses on the vagal afferents. CCK is released 
from enterochromaffin I-cells when proteins and lipids are 
taken into the GI tract. CCK then binds to CCK 1/A receptors 
on the vagal afferents or NG, thus causing the vagal afferent 
nerve firing to increase (Moran et al., 1990; Berthoud and 
Patterson, 1996; Moriarty et al., 1997; Broberger et al., 2001; 
Patterson et al., 2002). Ghrelin on the other hand, is released 
from enterochromaffin X/A-cells during the fasting state. 
Ghrelin acts on the growth-hormone secretgogue receptor 
A on both the vagal afferents and NG to inhibit vagal afferent 
firing (Kojima et al., 1999; Date et al., 2000, 2005; Page et al., 
2007). Other gut peptides act on and alter vagal afferent firing 
such as: leptin, bombesin, PYY, secretin, GLP-1, serotonin, and 
VIP. The actions of CCK, ghrelin, and these other gut peptides 
have been thoroughly reviewed (Grabauskas and Owyang, 
2017). The expression of the receptors of these gut peptides 
have been shown to change based on the nutrient state of 
the organism (Grabauskas and Owyang, 2017); demonstrating 
plasticity under normal physiological conditions. 
The fibers which carry the detected mechanical and 
chemical stimuli can be classified into two primary groups: 
lightly myelinated A-type and unmyelinated C-type afferent 
fibers (Schild et al., 1994). A- and C-fibers have different 
biophysical properties which have been thoroughly reviewed 
(Browning, 2003). The types of fibers can be distinguished 
by their myelination, firing rate, conduction velocity, and 
action potential kinetics. A-fibers are lightly myelinated, 
tonic firing neurons with a conduction velocity of 3–30 m/s 
and unremarkable action potentials. While C-fibers are 
unmyelinated, phasic firing neurons with a conduction 
velocity of 0.8–1.2 m/s and distinguishing action potentials. 
C-fibers make up 80–90% of the vagal afferents and have a 
noticeable hump during the repolarization phase of their 
action potential. A- and C- fibers are also distinguished by 
their different ion channels which contribute to their action 
potential. Of particular importance, IKCa
S, ID, IA, IH, TTX-S and 
TTX-R INa, and T- and L- type ICa currents give vagal afferent 
fibers unique action potential features depending upon the 
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ion channel expression (Schild et al., 1994). 
Beyond A- and C-fibers, vagal afferents can also be classified 
by their neurochemistry. The neurochemistry of the vagal 
afferent neurons of the NG includes the neurotransmitters 
glutamate, catecholamines, serotonin, and acetylcholine, as 
well as a considerable number of neuropeptides including 
substance P, neurokinin A, vasoactive intestinal peptide, 
calcitonin gene-related peptide, galanin, encephalin, 
somatostatin, CCK, neuropeptide Y, calcium-binding proteins, 
and other neuroactive molecules (i.e., nitric oxide; Zhuo et 
al., 1997). Additionally, beyond the mechanical and chemical 
stimuli, there is emerging evidence that vagal afferents 
transmit nociceptive information (Surdenikova et al., 2012). 
Transient receptor potential (TRP) channels have been 
shown to be expressed in GI-projecting vagal afferents (Yu et 
al., 2016). These fibers respond to acid, heat, cold, stretch, 
capsaicin, menthol, inflammatory mediators, and other 
stimuli which are associated with pain. Together under normal 
conditions, these vagal afferents contribute to the precise 
control and modulation of GI functions.
Altered Physiology of Gastrointestinal Vagal 
Afferents Following Neurotrauma
Since the mid-nineteenth century, GI comorbidities have been 
noted with CNS traumas (Cushing, 1932). These profound 
changes to the GI system after CNS trauma suggest there 
is VN involvement. In other pathophysiological states such 
as high fat diet, diabetes, inflammation, and direct vagal 
injury (Browning, 2003; Browning and Mendelowitz, 2003; 
Li and Owyang, 2003; Raybould, 2010; Dockray and Burdyga, 
2011; Kentish and Page, 2014; de Lartigue, 2016; Travagli 
and Anselmi, 2016; Browning et al., 2017; Grabauskas and 
Owyang, 2017; Cawthon and de La Serre, 2018; de Lartigue 
and Xu, 2018), vagal afferents have been shown to be 
extremely plastic. The combination of GI dysfunction and 
vagal afferent plasticity in other pathophysiological models 
suggests vagal afferent plasticity after CNS trauma, as well. 
Therefore, this section focuses on the altered physiology of 
vagal afferents following neurotrauma and identifies major 
knowledge gaps within the field. 
Traumatic brain injury 
Vagal afferent plasticity following TBI is significantly 
understudied, yet, it is known that brain-gut axis (or 
neuroenteric axis; Bansal et al., 2010) disturbances are a 
major cause of GI dysfunction post-TBI (Browning and Travagli, 
2011; Kharrazian, 2015). Vago-vagal circuit disturbances 
contribute to several GI dysfunctions (Browning and Travagli, 
2011). Yet, the exact mechanisms of GI dysfunction following 
TBI remain unclear. Several functional bowel disorders, which 
lead to chronic GI disorders, are associated with long-term 
dysregulation of the autonomic nervous system (Tougas, 
2000). TBI commonly presents with neural deficits and 
autonomic dysfunctions and is capable of causing chronic GI 
disorders. However, the neural and autonomic dysregulation 
is variable across studies but often results in decreased 
GI motility among other GI complaints (Tougas, 2000). 
Autonomic imbalances, or dysautonomia, are hypothesized 
to occur when the sympathetic and parasympathetic divisions 
of the ANS fail to properly integrate signals between the brain 
and viscera (Baguley et al., 2008). Dysautonomia has been 
reported in 8–33% of TBI individuals and is characterized by 
chronic sympathetic over-activity (Kirk et al., 2012) which 
may suggest parasympathetic dysfunction. ANS dysfunction 
is evident following TBI (Esterov and Greenwald, 2017) and 
persistent disruption of brain-visceral axes may be one culprit 
of multi-organ dysfunction following TBI. However, we are 
interested in the vagal afferent signaling following the axis 
disturbances. 
The vago-vagal synaptic transmission is modulated by a variety 
of signals including afferent inputs and neurohormones (such 
as CCK; Browning and Travagli, 2011). Vagal afferent sensitivity 
can decrease depending on specific receptor activation. 
Particularly, CCK-A receptors have been found on vagal afferents 
(Li, 2007) and electrophysiological activation of these receptors 
alters the sensitivity of the fibers which then modulates 
efferent output to the GI tract. Decreased sensitivity, from 
activation of CCK-A receptors on vagal afferents, can directly 
affect second messenger systems in NTS neurons and activate 
GI-inhibitory efferent pathways in the circuit. This modulation 
and subsequent GI-inhibition has been shown experimentally 
with CCK (Browning and Travagli, 2011). In an animal model of 
TBI, several GI pathologies were discovered including gastric 
distension, intestinal dilation, and intestinal effusion suggesting 
delayed gastric emptying and paralytic ileus. Additionally, 
plasma and jejunum CCK levels were elevated in the post-TBI 
rats potentially altering the GI vagal afferent responses (Forster 
et al., 1990; Higham et al., 1997; Shoji et al., 1997; Hang et al., 
2004). Increased CCK levels following TBI may be one source 
Review
Figure 1 ｜ Major vagal afferent innervation.
The majority of the vagus nerve is comprised of sensory fibers and the 
cell bodies of vagal afferents are contained within the co-joined jugular 
and nodose ganglia. The afferent vagus innervates from the oral cavity to 
the transverse colon in humans, but tracing studies in rodent models have 
demonstrated afferent projections as caudal as the rectum, bladder, and 
reproductive tract. Vagal afferents carry mechanical and/or chemical sensory 
information to the caudal medulla, specifically the NTS and nucleus ambiguus. 
The cell bodies of the gastrointestinal viscera are distributed throughout the 
nodose ganglia (depicted in red) and vagally-mediated reflexes dominate 
esophageal and gastric reflexes. Functional alterations within all visceral 
organs following pathophysiological remodeling may become more 
pronounced in some disease and injury states. GI: Gastrointes tinal; NTS: 
nucleus tractus solitarius.
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of GI dysfunction through activation of the vago-vagal NTS-
inhibitory pathway from altered vagal afferent input. 
Vagal afferent inputs to NTS neurons are further influenced 
by tumor necrosis factor alpha (TNF-α; Travagli et al., 2006). 
In a preclinical model, TNF-α has been shown to favor the 
GI-inhibitory state by acting on the vago-vagal circuit (Emch 
et al., 2000). Specifically, it has been shown to cause gastric 
stasis (Hermann et al., 2005) through modulation of NTS-
DMV synaptic transmission. Experimental models have 
revealed increased circulating TNF-α following TBI (Taupin 
et al., 1993; Tchelingerian et al., 1993; Shohami et al., 1994; 
Fan et al., 1996; Gourin and Shackford, 1997; Knoblach et al., 
1999; Schmidt et al., 2005), alters synaptic transmission by 
selectively activating inhibitory or inhibiting excitatory NTS 
neurons which then synapse with DMV neurons for efferent 
outflow. The modulation occurs through changes in the glial 
environment, specifically through astrocyte gene expression 
changes which may cause long-term changes in the sensitivity 
of the vago-vagal circuit. The glial-neuronal communication 
may be responsible for leading to the activation of the GI-
inhibitory efferent output and potentially be a therapeutic 
target. However, while TNF is elevated post-TBI, TNF has 
displayed both neuroprotective and neurotoxic effects in 
various models of CNS injury (Longhi et al., 2013). 
Additional preclinical studies investigating the glial-neuronal 
communication between astrocytes and NTS neurons 
(Hermann et al., 2009; Vance et al., 2015) have also been 
found to disrupt vago-vagal circuitry. In a rat model, Hermann 
et al. (2009) showed a significant reduction in gastric transit 
by using a protease-activated receptor agonist to mimic the 
autonomic disruption first described by Cushing (1932) which 
occurs following a bleeding head injury. In this study, the 
interaction of thrombin with protease-activated receptors in 
the dorsal vagal complex activated astrocytes which in turn 
excited inhibitory-NTS neurons evoking inhibition of gastric 
motility. It is important to note that the autonomic astrocytes 
may play a role similar to that of neurons in the vago-vagal 
circuitry. The glial-neural interactions are multi-directional and 
visceral afferent inputs regulate astrocyte activity (McDougal 
et al., 2011; Accorsi-Mendonça et al., 2013). Therefore, 
alterations in vagal afferent input following TBI, may affect 
more than the neuronal synapses in the vago-vagal circuit. 
Modification of the vago-vagal reflex circuit following TBI, 
remains a contributing factor of brain-gut axis disruption 
(Kharrazian, 2015). These vago-vagal alterations are largely 
involved in GI dysfunction and elicit greater research on the 
vagal afferent changes post-TBI.
Lastly, in a mouse model of TBI, Bansal et al. (2009) showed 
that following TBI, intestinal permeability increased while 
protein expression of cell junction proteins decreased. 
Furthermore, there was an increase in intestinal TNF-α and 
other investigators have also reported increased expression 
of inflammatory cytokines post-TBI (Hang et al., 2005a, b; 
Katzenberger et al., 2015). While it is not clear whether the 
inflammation leads to the increased intestinal permeability, 
a preclinical study used a knockout mouse model equipped 
against inflammation to support the hypothesis that specific 
pro-inflammatory cytokines correlate with higher intestinal 
permeability following TBI (Jin et al., 2008). Yet, the source of 
intestinal inflammation post-TBI remains unclear. Alternatively, 
the source of increased intestinal permeability has been 
proposed as a heightened adrenergic state post-TBI, further 
highlighting the significance of a healthy brain-gut axis in 
proper gut functioning (Bansal et al., 2009). 
The significance of diminished barrier integrity and heightened 
inflammatory state is revealed in an animal study by Ammori 
et al. (2008) that reported cellular degeneration in DMV vagal 
efferent neurons following experimental colitis. The potential 
for inflammatory cytokines to traverse the gut-brain axis (or 
enteric-neuro axis) and negatively affect neuronal survival 
provides another source of vago-vagal alteration (Bansal et 
al., 2010). Furthermore, preclinical studies reveal significant 
ENS changes caused by intestinal inflammation such as 
neuronal loss (Sanovic et al., 1999), hyperexcitability (Linden 
et al., 2003), and altered neurotransmitter release (Linden 
et al., 2005) causing changes in sensory interoceptive input 
and DMV structure (Ammori et al., 2008). Consistent with 
the negative impact of intestinal inflammation on neuronal 
populations of DMV and ENS neurons, DMV apoptosis is 
reversed by the anti-inflammatory role of ghrelin in an animal 
model (Qi et al., 2011). In addition to the cell loss, the time 
course of neuronal damage and plasticity caused by intestinal 
inflammation post-TBI is unknown. 
Spinal cord injury
There is limited research investigating GI vagal function and 
plasticity in human SCI individuals. Of the few clinical studies 
examining SCI vagal function in general, one study utilized 
functional magnetic resonance imaging to measure brain 
activation from bladder fullness in complete SCI individuals 
(Krhut et al., 2017). Krhut et al. (2017) found a subset of 
subjects that had activation in nuclei (NTS and parabrachial 
nucleus) associated with vagal afferent activity. Under 
normal conditions these nuclei are not activated by bladder 
fullness, and suggest following SCI, there is vagal afferent 
plasticity or collateral sprouting occurring to re-innervate the 
bladder. Studies investigating female genital sensation after 
complete SCI also demonstrated new NTS activation, similarly 
suggesting new vagal afferent plasticity after SCI (Whipple 
and Komisaruk, 2002; Komisaruk et al., 2004). These studies 
demonstrate vagal plasticity after SCI, and GI vagal afferent 
dysfunction could be a promising avenue for further clinical 
research. 
Preclinical rodent models of SCI also exhibit GI dysfunction. 
Our lab along with Gondim et al. have shown delayed gastric 
emptying and decreased GI transit time in SCI rats (Gondim 
et al., 1998; Tong and Holmes, 2009; Qualls-Creekmore et 
al., 2010) indicating a disruption in the vago-vagal reflexes. 
Gondim and colleagues’ studies were the first to observe 
an upper thoracic (T1 or T5) spinal cord transection in rats 
leads to delayed gastric emptying and delayed GI transit of 
liquid (Gondim et al., 1998, 2001; Rodrigues et al., 2001). We 
expanded these findings by demonstrating that upper thoracic 
T3-SCI animals show a diminished food intake (Primeaux et 
al., 2007), a significant reduction in gastric motility (Tong and 
Holmes, 2009) that lasts as long as 6 weeks after injury, and 
a delay in gastric emptying of a 13C-tagged solid meal (Qualls-
Creekmore et al., 2010). It has been hypothesized that GI 
dysfunction is due to a vagally-mediated mechanism (Gondim 
et al., 2001; Tong and Holmes, 2009; Holmes, 2012).
Our lab has further found that vagal efferents remain 
anatomically and functionally intact after T3-SCI (Swartz 
and Holmes, 2014) but are silent due to lack of presynaptic 
stimuli (Tong et al., 2011). For example, NTS neurons are not 
activated after central or peripheral administration of CCK-
8s in a T3-SCI model but respond to other depolarizing drugs, 
such as 4-aminopyridine, suggesting that afferents within the 
NTS are capable of releasing neurotransmitters but are not 
stimulated by GI peptides (Tong et al., 2011). However, the 
NTS receives afferent input from many brain regions, vagal 
afferents, and spinal afferents; therefore, this study could not 
conclude that the vagal afferents were altered specifically. 
Our most recent study demonstrates directly that vagal 
afferents are hyposensitive to stimuli, both chemical and 
mechanical, after SCI (Besecker et al., 2020). We confirmed 
hyposensitivity of vagal chemoreceptors to CCK-8s and 
demonstrated novel mechanical hyposensitivity to von 
Frey Hair stimuli, and interestingly, TRPV1 receptor agonist, 
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capsaicin, showed hypersensitivity in vagal afferents after SCI. 
These data suggest SCI provokes exceptional functional vagal 
plasticity and impairs vagal afferent signaling necessary for 
proper GI reflexes. Furthermore, another recent study of ours 
has reported this hyposensitivity is not specific to CCK and 
mechanical stimuli, but includes ghrelin (Besecker et al., 2018) 
and may involve other GI peptides not yet tested (Besecker et 
al., 2017). 
A recent investigation in a chronic SCI rodent model, studied 
vagal afferents as a whole (i.e., not organ specific; Herrity 
et al., 2015). They demonstrated that SCI impacts the 
neurochemical characteristics of vagal afferents, by increasing 
P2X3 receptor expression and decreasing isolectin 4 binding 
in whole NG (Herrity et al., 2014). This study demonstrated 
SCI has the ability to change the phenotype of vagal afferents, 
but specific changes within GI vagal afferents remain to be 
determined.
Based upon these studies, we propose that SCI-induced 
pathophysiological plasticity occurs within vagal afferents 
and NG though the degree remains unknown. Multiple 
mechanisms can be proposed to account for the loss-of-
function in vagal afferents, such as altered trafficking of 
receptors, receptor plasticity and/or adaptation, disruption 
of intracellular signaling pathways, ionic imbalances, 
degeneration of nerve endings, or loss of function of 
gated ion channels. In the case of SCI, it is unknown what 
electrophysiological phenotype is exhibited in vagal afferents 
after injury. However, following SCI in rodent models, other 
sensory afferents, such as the dorsal root ganglia, have shown 
to have both decreased (Yoshimura and de Groat, 1997; Black 
et al., 2003) and increased (Black et al., 2003; Yang et al., 
2014) expression and function of TTX-R NaV channels: thus, 
resulting in hyperexcitability or hypoexcitability of sensory 
afferents depending on the target organ they innervate 
similar to what is seen in vagal afferents in our SCI model 
(Besecker et al., 2020). Other voltage-gated channels, such 
as KV3.4 (Ritter et al., 2015), in dorsal root ganglia have been 
shown to be altered by SCI, as well. The SCI-induced changes 
in electrophysiological properties of sensory afferents have 
not been expanded to the vagal afferents, thus opening more 
promising avenues for further research. 
Gastrointestinal Microbiome 
The GI microbiome plays a critical role in health and disease 
(Kigerl et al., 2016; Sherwin et al., 2016; O’Connor et al., 
2018). The bidirectional pathway or the microbiota-gut-brain 
axis (Rhee et al., 2009; Bercik, 2011; Cryan and O’Mahony, 
2011; Cryan and Dinan, 2012; Burokas et al., 2015; Mayer et 
al., 2015) is emerging as a critical communication line between 
the GI microbiome and brain (Sherwin et al., 2018) via the VN, 
immune mediators, microbial metabolites, and modulation 
of circulating tryptophan (O’Mahony et al., 2015; Scott et al., 
2015; Foster et al., 2016; Sarkar et al., 2016; Sherwin et al., 
2016). GI microbes indirectly influence neural communication, 
such as the vagal afferents, via the production of metabolites 
(e.g., short-chain fatty acids), synthesis of neurotransmitters 
(e.g.,  gamma-aminobutyric acid, noradrenaline, and 
dopamine), and immune system modulation (Sherwin et 
al., 2016). Disruptions in the microbiota-gut-brain axis of 
the VN contribute to both GI (Mulak and Bonaz, 2004; 
Bonaz and Bernstein, 2013; Oświęcimska et al., 2017) and 
neurodegenerative disorders (Cenit et al., 2017; Kobayashi et 
al., 2017; Quigley, 2017). Vagal afferents use gut endocrine 
cell interactions (Raybould, 2010), direct and receptor 
activation (Goehler et al., 1999; Lal et al., 2001), and CCK-
mediated mechanisms (Lal et al., 2001) to detect GI microbial 
compounds or metabolites and carry the information to the 
brain. The NG contributes to the brain-relay by responding 
to bacterial products such as lipopolysaccharide (Hosoi et al., 
2005). Information along the vagal pathway reaches the brain 
to elicit adaptations or inappropriate responses, the latter 
contributes to GI and neurodegenerative pathophysiologies 
(Eisenstein, 2016; Tse, 2017). 
While several preclinical studies have shown vagal nerve 
activity in response to GI microbes (Gaykema et al., 2004; 
Tanida et al., 2005; Raybould, 2010; Bravo et al., 2011; Perez-
Burgos et al., 2013), clinical vagal afferent activation via GI 
microbiota remains hypothetical (Bonaz et al., 2018). For 
further review of GI microbiota and the microbiome-gut-brain 
axis, please see (Burnet and Cowen, 2013; Wang and Kasper, 
2014; Kelly et al., 2015; Moos et al., 2016). Additionally, a 
preclinical model has shown evidence of gut microbiota 
modulating satiety signals, specifically increasing GLP-1 and 
PYY plasma levels, favoring anorexigenic signaling to the brain 
(Breton et al., 2016); such GI microbiota influence on feeding 
behaviors may be responsible for the GI dysfunction following 
neurotrauma. Gaining a better understanding of the influence 
altered gut microbes have on the brain following trauma, may 
lead to interventions for reduced comorbidities and improved 
functional outcomes. However, there are limited clinical 
studies on the microbiome-gut-brain axis following TBI and SCI 
(O’Connor et al., 2018). 
Dysbiosis following traumatic brain injury 
Dysbiosis is a result of pathogenic bacteria outnumbering 
beneficial nonpathogenic gut bacteria resulting in undesired 
health outcomes. GI dysbiosis occurs within 2 to 24 hours after 
TBI (Treangen et al., 2018; Nicholson et al., 2019) and remains 
altered in chronic TBI (Ma et al., 2017) in rodent models. In the 
study by Treangen et al. (2018) the microbiota changes post-
TBI include decreased Ruminococcus flavieciens, increased 
Eubacterium ventriosum, and increased Marvinbryantia 
formatexigens. Thus, this study demonstrated a change in 
Firmicutes/Bacteroidetes ratio and succinate-producing 
microbes. Sherwin et al. (2018) noted that the surge in SNS 
activation may be responsible for altering post-TBI microbiota 
as observed in a study in mice (Houlden et al., 2016). This 
work demonstrated a decrease in the intestinal microbiota 
family Prevotellaceae post-TBI, while levels of norepinephrine 
release and noradrenergic innervation in the cecum increased 
in mice (Houlden et al., 2016). Additionally, norepinephrine 
levels have been shown to increase, in both animal and human 
studies, following trauma (Millen et al., 1985; Woolf et al., 
1992; Lyte and Bailey, 1997) exuding a sympathetic dominance 
which may contribute to the GI dysfunction. However, 
norepinephrine has recently been shown to reduce the relative 
abundance of certain species of the genus Prevotella (from 
the family Prevotellaceae) in vitro (Jentsch et al., 2013). Less 
is understood about the family Peptococcaceae, but increases 
(as demonstrated in mice (Houlden et al., 2016)) have been 
correlated with increased expression of the proinflammatory 
cytokine (CCL5) which has been linked to colitis development 
(Elinav et al., 2011) in mice.
The work by Durham et al. (2016) as well as several other 
studies (Rogers et al., 2016; Duvallet et al., 2017; Sun and 
Shen, 2018; Winter et al., 2018) indicate the involvement of 
the brain-gut axis in TBI-related neuropathologies which has 
recently expanded to include TBI-GI pathologies suggesting 
microbiome-gut-brain-axis (Mayer et al., 2015; Martin 
and Mayer, 2017; Sundman et al., 2017) disruption. The 
paradox remains in that GI microbial shifts alter VN activity 
(microbiota-gut-brain axis) and GI dysfunction alters GI 
microbial populations (brain-gut-microbiota axis). However, 
evidence is beginning to indicate that probiotic treatments 
may be capable of healing the injured brain by repairing post-
TBI gut dysbiosis (Treangen et al., 2018). 
Dysbiosis following spinal cord injury
Reviews of the current SCI microbiome literature can be 
Review
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found in (Holmes and Blanke, 2019; Wallace et al., 2019) but 
briefly, investigators have shown that gut dysbiosis occurs 
following SCI. Similar to the TBI-microbiome preclinical study, 
Kigerl et al. (2016) showed that the Firmicutes/Bacteroidetes 
ratio also increased following SCI in mice. Additionally, in 
another SCI rodent model, the following GI microbiota 
changes were detected: increased Lactobacillus intestinalis, 
Clostridium disporicum, and Bifidobacterium choerinum while 
relative abundance of Clostridium saccharogumia decreased 
(O’Connor et al., 2018). High prevalence of Lactobacillaceae 
family has been correlated with carbohydrate fermentation to 
lactic acid, and Kigerl et al. (2016) revealed post-SCI functional 
recovery correlations to lactic acid supplementation. 
Clostridium spp. have been found to be both helpful and 
harmful but the functional implications of C. disporicum 
remain to be further understood. In humans, the family of 
Bifidobacteriaceae is probiotic and found in healthy guts 
conferring positive health benefits (O’Callaghan et al., 2015). 
Lastly, while literature reveals deleterious effects on the host 
when C. saccharogumia is depleted, the significance of this 
is low with the increased relative abundance of the other 
commensal microbes (O’Connor et al., 2018). 
These microbiota changes were inversely correlated 
with intestinal inflammatory changes. The intestinal 
proinflammatory cytokines likely suppressed microbial taxa 
responsible for butyrate production in the GI tract. Butyrate 
plays a critical role in gut health through its anti-inflammatory 
properties by supporting intestinal cell cycles, its pathogen-
protection activities, modulation of the immune system, 
and reduction of cancer progression (Gungor et al., 2016; 
O’Connor et al., 2018). Previous preclinical studies analyzed 
the effects of Faecalibacterium prausnitzii, a known butyrate-
producing microbe, and found it to have protective effects 
on the gut (Miquel et al., 2013). O’Connor et al. (2018) noted 
F. prausnitzii to be depleted in SCI mice with significantly 
increased levels of proinflammatory cytokines (Miquel et 
al., 2013; Kigerl et al., 2016). Similarly, a decrease in the 
abundance of butyrate-producing bacteria correlates with gut 
dysbiosis in clinical SCI (Ferrante et al., 2003; Sun et al., 2015; 
Butchbach et al., 2016; Gungor et al., 2016; Li et al., 2016). 
As observed with the TBI-microbiota changes, the microbial 
shift post-SCI is towards a recovery profile to the host; yet 
many health-related microbes are depleted due to the chronic 
inflammatory state of the GI tract post-neurotrauma.
While much remains to be understood with microbiota effects 
on system physiology, characterizing GI microbiota is critical 
following neurotrauma. The characterization, identification of 
physiological roles, and determination of critical time-points 
of the changing microbiota will help in designing therapeutic 
interventions for TBI- and SCI-related GI comorbidities. 
Conclusion 
Neurotrauma causes profound changes to ANS control of the 
GI system. GI dysfunction contributes to increased morbidity 
and mortality. However, neural plasticity offers the ability to 
target specific mechanisms and treat GI dysfunctions following 
CNS injury, but the exact mechanisms of disruption remain 
largely under-researched. Following TBI, the GI vagal afferents 
exhibit modified receptor-, peptide-, and glial-interactions 
which favor the inhibitory-NTS vagal efferent pathway. Vagal 
efferent and ENS neuronal populations decrease following 
intestinal inflammatory insult, and may be an on-going cycle 
across synapses in the vago-vagal reflex circuit. These vagal 
afferent and efferent interactions and reactions may serve as 
suitable therapeutic targets in repairing GI dysfunction post-
TBI, but the exact mechanisms which contribute to these 
changes and the system-wide interactions from such plasticity 
need to be better understood. 
The effects of SCI on GI dysfunction still remains a significant 
knowledge gap. From the above studies, we know human 
vagal afferents show significant re-wiring post-SCI to activate 
once-quiet NTS neurons. This modified afferent input 
following SCI remains unclear but shows potential for re-
activation of vago-vagal reflexes. In animal models of SCI, it 
has been shown that GI vago-vagal reflexes are disrupted. 
While the vagal efferents remain intact, they fail to respond 
spontaneously due to lack of presynaptic stimuli. This further 
suggests vagal afferent alterations. Furthermore, we have 
reported that GI vagal afferents are hyposensitive to chemical 
and mechanical stimuli but selectively hypersensitive to 
noxious chemical stimuli. Lastly, SCI changes phenotypic 
profiles of NG by increasing P2X3 receptor expression and 
decreasing isolectin 4 binding. While little is known about 
the plasticity of GI-vagal afferents following SCI, the research 
suggests that vago-vagal reflexes are affected and responsive 
to changing conditions. Upon further understanding of the 
mechanisms of plasticity in the vago-vagal circuit, we will 
strengthen the efforts of finding treatments for GI pathologies 
following neurotrauma. 
There is an emerging discussion that neurotrauma is a 
systemic pathology (Figure 2). The vago-vagal reflex circuit 
is anatomically intact after TBI and SCI, suggesting the 
derangements to the GI vago-vagal reflexes must be due to a 
secondary cascade of events. The components of the vago-
vagal reflex are optimally poised to sense secondary events 
such as systemic inflammation. Immediately following trauma 
to the CNS, regardless of location, a systemic inflammatory 
response (SIR) ensues (Anthony and Couch, 2014; Schwab 
et al., 2014; Sun et al., 2016). SIR following SCI has been 
thoroughly reviewed (Sun et al., 2016; Bloom et al., 2020). 
For SCI, the SIR is characterized by increased levels of 
circulating inflammatory mediators and cells, activation of 
resident glial and immune cells, and infiltration of neutrophils, 
macrophages and lymphocytes, all of which culminate in 
multiple organ failure (Sun et al., 2016; Bloom et al., 2020). 
The SCI-induced SIR is triggered within hours and persists 
for weeks following injury, and currently there is no clinical 
evidence to support the use of any neuroprotective drugs 
to improve functional outcomes after SCI (Popovich et al., 
2001; Campbell et al., 2005; Gris et al., 2008; Wing, 2008; 
Sauerbeck et al., 2015; Bloom et al., 2020). Studies of other 
inflammatory disease models have examined the effects 
of systemic inflammation on vagal afferents and have been 
reviewed (Browning et al., 2017). Briefly, inflammation has 
shown to decrease vagal afferent response to leptin and CCK, 
while increasing mechanosensitivity, TRP and P2X receptors 
and NaV channel expression (Browning et al., 2017). Our 
preclinical SCI reports of decreased GI vagal afferent response 
to CCK (Tong et al., 2011; Besecker et al., 2020), increased 
TRPV1 expression and hypersensitivity (Besecker et al., 2019), 
along with the preclinical report by Herrity et al. (2015) of 
increased P2X3 receptor expression in NG after SCI, insinuate 
a similar mechanism. This suggests systemic inflammation 
may cause pathophysiological plasticity within vagal afferents 
after SCI (Figure 2). Lastly, inflammation has been shown to 
alter the GI microbiota preclinically (O’Connor et al., 2018). 
The inflammatory profile causes dysbiosis causing disruption 
to the microbiota-gut-brain axis. This disruption may be 
the culprit of the chronic GI and neurological disorders 
seen in neurotrauma individuals. By understanding the GI 
microbiome, and developing a healthy gut profile, we may be 
equipped with probiotics necessary to reverse the long-term 
GI and neural deficits in TBI- and SCI individuals.
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